PMC:7014668 / 9959-10653 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"132","span":{"begin":71,"end":77},"obj":"Species"},{"id":"133","span":{"begin":408,"end":414},"obj":"Species"},{"id":"134","span":{"begin":62,"end":70},"obj":"Disease"},{"id":"135","span":{"begin":380,"end":384},"obj":"Disease"},{"id":"136","span":{"begin":506,"end":525},"obj":"Disease"},{"id":"137","span":{"begin":638,"end":646},"obj":"Disease"}],"attributes":[{"id":"A132","pred":"tao:has_database_id","subj":"132","obj":"Tax:9606"},{"id":"A133","pred":"tao:has_database_id","subj":"133","obj":"Tax:9606"},{"id":"A134","pred":"tao:has_database_id","subj":"134","obj":"MESH:D007239"},{"id":"A135","pred":"tao:has_database_id","subj":"135","obj":"MESH:D045169"},{"id":"A136","pred":"tao:has_database_id","subj":"136","obj":"MESH:C000657245"},{"id":"A137","pred":"tao:has_database_id","subj":"137","obj":"MESH:D007239"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Entry screening is an intuitive barrier for the prevention of infected people entering a country or region. However, evidence on its effectiveness remains limited and given its lack of specificity, it generates a high overhead of screened travellers uninfected with the targeted pathogen [5]. For example, when entry screening was implemented in Australia in response to the 2003 SARS outbreak, 1.84 million people were screened, 794 were quarantined, and no cases were confirmed [12]. While some cases of 2019-nCoV infection have been identified through airport screening in the current outbreak, our estimates indicate that likely more infected travellers have not been detected by screening."}

    LitCovid-PD-MONDO

    {"project":"LitCovid-PD-MONDO","denotations":[{"id":"T32","span":{"begin":380,"end":384},"obj":"Disease"},{"id":"T33","span":{"begin":506,"end":525},"obj":"Disease"},{"id":"T34","span":{"begin":516,"end":525},"obj":"Disease"}],"attributes":[{"id":"A32","pred":"mondo_id","subj":"T32","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A33","pred":"mondo_id","subj":"T33","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A34","pred":"mondo_id","subj":"T34","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"}],"text":"Entry screening is an intuitive barrier for the prevention of infected people entering a country or region. However, evidence on its effectiveness remains limited and given its lack of specificity, it generates a high overhead of screened travellers uninfected with the targeted pathogen [5]. For example, when entry screening was implemented in Australia in response to the 2003 SARS outbreak, 1.84 million people were screened, 794 were quarantined, and no cases were confirmed [12]. While some cases of 2019-nCoV infection have been identified through airport screening in the current outbreak, our estimates indicate that likely more infected travellers have not been detected by screening."}

    LitCovid-PD-CLO

    {"project":"LitCovid-PD-CLO","denotations":[{"id":"T33","span":{"begin":87,"end":88},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T34","span":{"begin":211,"end":212},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"Entry screening is an intuitive barrier for the prevention of infected people entering a country or region. However, evidence on its effectiveness remains limited and given its lack of specificity, it generates a high overhead of screened travellers uninfected with the targeted pathogen [5]. For example, when entry screening was implemented in Australia in response to the 2003 SARS outbreak, 1.84 million people were screened, 794 were quarantined, and no cases were confirmed [12]. While some cases of 2019-nCoV infection have been identified through airport screening in the current outbreak, our estimates indicate that likely more infected travellers have not been detected by screening."}

    LitCovid-sentences

    {"project":"LitCovid-sentences","denotations":[{"id":"T67","span":{"begin":0,"end":107},"obj":"Sentence"},{"id":"T68","span":{"begin":108,"end":292},"obj":"Sentence"},{"id":"T69","span":{"begin":293,"end":485},"obj":"Sentence"},{"id":"T70","span":{"begin":486,"end":694},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Entry screening is an intuitive barrier for the prevention of infected people entering a country or region. However, evidence on its effectiveness remains limited and given its lack of specificity, it generates a high overhead of screened travellers uninfected with the targeted pathogen [5]. For example, when entry screening was implemented in Australia in response to the 2003 SARS outbreak, 1.84 million people were screened, 794 were quarantined, and no cases were confirmed [12]. While some cases of 2019-nCoV infection have been identified through airport screening in the current outbreak, our estimates indicate that likely more infected travellers have not been detected by screening."}

    2_test

    {"project":"2_test","denotations":[{"id":"32046816-25695520-29321271","span":{"begin":289,"end":290},"obj":"25695520"},{"id":"32046816-14984341-29321272","span":{"begin":481,"end":483},"obj":"14984341"}],"text":"Entry screening is an intuitive barrier for the prevention of infected people entering a country or region. However, evidence on its effectiveness remains limited and given its lack of specificity, it generates a high overhead of screened travellers uninfected with the targeted pathogen [5]. For example, when entry screening was implemented in Australia in response to the 2003 SARS outbreak, 1.84 million people were screened, 794 were quarantined, and no cases were confirmed [12]. While some cases of 2019-nCoV infection have been identified through airport screening in the current outbreak, our estimates indicate that likely more infected travellers have not been detected by screening."}

    MyTest

    {"project":"MyTest","denotations":[{"id":"32046816-25695520-29321271","span":{"begin":289,"end":290},"obj":"25695520"},{"id":"32046816-14984341-29321272","span":{"begin":481,"end":483},"obj":"14984341"}],"namespaces":[{"prefix":"_base","uri":"https://www.uniprot.org/uniprot/testbase"},{"prefix":"UniProtKB","uri":"https://www.uniprot.org/uniprot/"},{"prefix":"uniprot","uri":"https://www.uniprot.org/uniprotkb/"}],"text":"Entry screening is an intuitive barrier for the prevention of infected people entering a country or region. However, evidence on its effectiveness remains limited and given its lack of specificity, it generates a high overhead of screened travellers uninfected with the targeted pathogen [5]. For example, when entry screening was implemented in Australia in response to the 2003 SARS outbreak, 1.84 million people were screened, 794 were quarantined, and no cases were confirmed [12]. While some cases of 2019-nCoV infection have been identified through airport screening in the current outbreak, our estimates indicate that likely more infected travellers have not been detected by screening."}